Tiverton Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$3.91M Sell
23,228
-3,429
-13% -$559K 0.14% 140
2019
Q2
$4.46M Buy
26,657
+8,277
+45% +$1.15M 0.16% 131
2019
Q1
$2.69M Buy
18,380
+9,505
+107% +$1.38M 0.12% 150
2018
Q4
$1.19M Sell
8,875
-4,127
-32% -$677K 0.07% 161
2018
Q3
$2.48M Hold
13,002
0.12% 128
2018
Q2
$2.17M Buy
13,002
+9,716
+296% +$1.56M 0.11% 132
2018
Q1
$553K Sell
3,286
-1,598
-33% -$268K 0.04% 204
2017
Q4
$799K Buy
+4,884
New +$876K 0.05% 198
2017
Q2
Sell
-28,943
Closed -$6.92M 184
2017
Q1
$6.92M Sell
28,943
-15,643
-35% -$3.64M 0.35% 97
2016
Q4
$9.36M Buy
44,586
+15,643
+54% +$3.24M 0.56% 70
2016
Q3
$6.67M Buy
+28,943
New +$7.07M 0.53% 71
2016
Q2
Sell
-83,222
Closed -$22.3M 159
2016
Q1
$22.3M Sell
83,222
-7,778
-9% -$2.23M 0.76% 50
2015
Q4
$28.5M Sell
91,000
-49,000
-35% -$14.6M 0.9% 37
2015
Q3
$38.1M Buy
+140,000
New +$43M 0.84% 47

Other funds holding AGN

Tiverton Asset Management's AGN Position: Q3 2019 in Review

Tiverton Asset Management reduced its Allergan plc (AGN) stake by 13% in Q3 2019, selling an estimated $559K and leaving 23,228 shares worth $3.91M. The position accounts for 0.14% of the portfolio, ranked #140.

Tiverton Asset Management first reported a position in AGN in Q3 2015 and has held it in 14 quarters since. The position peaked at $38.1M in Q3 2015. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Tiverton Asset Management held 23,228 shares of Allergan plc worth $3.91M as of Q3 2019.
  • Tiverton Asset Management sold 3,429 Allergan plc shares in Q3 2019, an estimated $559K.
  • Allergan plc made up 0.14% of Tiverton Asset Management's portfolio in Q3 2019, its #140 holding.
  • Tiverton Asset Management first reported a position in Allergan plc in Q3 2015 and has held it in 14 quarters since.
  • Tiverton Asset Management's Allergan plc position peaked at $38.1M in Q3 2015.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.